• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三级医疗中心的乳腺癌模式。

Pattern of breast cancer in a tertiary care center.

作者信息

Jha A K, Hamal P K, Jha J, Banthia P, Thakali K, Basnet B K

机构信息

BP Koirala Memorial Cancer Hospital, Bharatpur, Chitwan, Nepal.

出版信息

JNMA J Nepal Med Assoc. 2010 Jan-Mar;49(177):1-5.

PMID:21180211
Abstract

INTRODUCTION

Breast Cancer is the second commonest cause of cancer death in women. Almost all women survive breast cancer if it is detected before it starts to spread. The aim of the study is to analyze the demographical profile, stage of presentation, histological type, and treatment modalities of breast cancer in a tertiary care setting.

METHODS

Total 1141 cases of breast cancer had been followed retrospectively from 1999 to 2006 A.D. in a tertiary care center and their patterns were analyzed.

RESULTS

The mean age of presentation of breast cancer was 47.30 +/- 11.57 years in female and 59.03 +/- 14.63 in male, 31 (2.1%) cases of breast cancer were male. There were 123 (10.78%) stage I, 281 (24.62%) stage II, 466 (40.84%) stage III, and 271 (23.75%) stage IV patients. Infiltrating ductal carcinoma was the commonest variety 610 (53.5%). Chemotherapy was the mainstay for treatment of breast cancer 341 (29.9%) followed by surgery 287 (25.2%).

CONCLUSIONS

Breast cancer trend is rising with more in late and advanced stages, mostly due to lack of awareness. Infiltrating ductal carcinoma is the commonest variety. Chemotherapy is the most commonly used modality of treatment. Male breast cancer present late and is not so uncommon.

摘要

引言

乳腺癌是女性癌症死亡的第二大常见原因。如果在乳腺癌开始扩散之前被检测到,几乎所有女性都能存活。本研究的目的是分析三级医疗机构中乳腺癌的人口统计学特征、就诊阶段、组织学类型和治疗方式。

方法

对一家三级医疗机构1999年至2006年期间回顾性随访的1141例乳腺癌病例及其模式进行了分析。

结果

女性乳腺癌患者的平均就诊年龄为47.30±11.57岁,男性为59.03±14.63岁,31例(2.1%)乳腺癌患者为男性。有123例(10.78%)处于I期,281例(24.62%)处于II期,466例(40.84%)处于III期,271例(23.75%)处于IV期。浸润性导管癌是最常见的类型,有610例(53.5%)。化疗是乳腺癌治疗的主要方式,有341例(29.9%),其次是手术,有287例(25.2%)。

结论

乳腺癌的发病趋势呈上升态势,晚期和进展期病例增多,主要原因是缺乏认识。浸润性导管癌是最常见的类型。化疗是最常用的治疗方式。男性乳腺癌就诊时病情较晚,且并不罕见。

相似文献

1
Pattern of breast cancer in a tertiary care center.三级医疗中心的乳腺癌模式。
JNMA J Nepal Med Assoc. 2010 Jan-Mar;49(177):1-5.
2
Histomorphological spetrum of breast lesions.乳腺病变的组织形态学谱
J Nepal Health Res Counc. 2011 Apr;9(1):48-51.
3
[Breast cancer in men: are there similarities with breast cancer in women?].[男性乳腺癌:与女性乳腺癌有相似之处吗?]
Gynecol Obstet Fertil. 2006 May;34(5):413-9. doi: 10.1016/j.gyobfe.2006.03.014. Epub 2006 Apr 21.
4
[Breast cancer in Tunisia: clinical and epidemiological study].[突尼斯的乳腺癌:临床与流行病学研究]
Bull Cancer. 1999 Mar;86(3):302-6.
5
Male breast cancer: a multicentric study.男性乳腺癌:一项多中心研究。
Breast J. 2007 Mar-Apr;13(2):213-5. doi: 10.1111/j.1524-4741.2007.00412.x.
6
[Breast cancer in Morocco: phenotypic profile of tumors].[摩洛哥的乳腺癌:肿瘤的表型特征]
Pan Afr Med J. 2016 Oct 6;25:74. doi: 10.11604/pamj.2016.25.74.9966. eCollection 2016.
7
Breast cancer in south-east Republic of Yemen.也门共和国东南部的乳腺癌
East Mediterr Health J. 2001 Nov;7(6):1012-6.
8
Cancer of the male breast.男性乳腺癌
Am Surg. 1994 Nov;60(11):816-20.
9
Breast cancer in Tunisia in 2004: a comparative clinical and epidemiological study.2004年突尼斯的乳腺癌:一项临床与流行病学对比研究。
Bull Cancer. 2008 Feb;95(2):E5-9. doi: 10.1684/bdc.2008.0584.
10
[Clinical research advancement on male breast cancer].[男性乳腺癌的临床研究进展]
Ai Zheng. 2007 Oct;26(10):1148-52.

引用本文的文献

1
Quality of Life of Nepalese Women Post Mastectomy.尼泊尔女性乳房切除术后的生活质量。
Asian Pac J Cancer Prev. 2018 Apr 25;19(4):1005-1012. doi: 10.22034/APJCP.2018.19.4.1005.
2
Preliminary Study on Serum Lactate Dehydrogenase (LDH)-Prognostic Biomarker in Carcinoma Breast.乳腺癌血清乳酸脱氢酶(LDH)预后生物标志物的初步研究
J Clin Diagn Res. 2016 Mar;10(3):BC06-8. doi: 10.7860/JCDR/2016/17111.7364. Epub 2016 Mar 1.